|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current Assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash, current | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Inventory | ||||||||||||||||||
| Costs capitalized to obtain contracts, net | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Restricted cash, noncurrent | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Costs capitalized to obtain contracts, noncurrent | ||||||||||||||||||
| Investments | ||||||||||||||||||
| Prepaid expenses and other assets, noncurrent | ||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Escrow liability | ||||||||||||||||||
| Convertible notes, current | ||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Convertible notes, net, noncurrent | ||||||||||||||||||
| Derivative liability, noncurrent | ||||||||||||||||||
| Deferred revenue, noncurrent | ||||||||||||||||||
| Other liabilities, noncurrent | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||
| Common Stock, $0.001 par value; 500,000,000 authorized as of September 30, 2026 and December 31, 2025; 82,570,784 issued and 81,589,686 outstanding as of September 30, 2026 and 79,359,589 issued and outstanding as of December 31, 2025 | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Notes due from affiliates | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||
| Treasury stock, at cost; 981,098 and 0 shares as of September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||
Loading...